This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Asahi Kasei Pharma Corporation. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Ken-Ichi Kasahara: Innovator in Pharmaceutical Compounds
Introduction
Ken-Ichi Kasahara is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various health issues.
Latest Patents
Ken-Ichi Kasahara holds a patent for benzothiazepine and benzothiepine compounds. This pharmaceutical is useful as a therapeutic agent and a preventive agent for hyperlipemia. It also serves as a therapeutic agent for hepatic disorders associated with cholestasis, particularly primary biliary cirrhosis and primary sclerosing cholangitis. Additionally, it is beneficial for obesity, fatty liver, and steatohepatitis.
Career Highlights
He is currently associated with Asahi Kasei Pharma Corporation, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing therapeutic options for patients suffering from complex health conditions.
Collaborations
Ken-Ichi has collaborated with notable colleagues, including Takehiko Sasahara and Mitsunobu Mohri. Their combined expertise has contributed to the success of their projects and the advancement of pharmaceutical research.
Conclusion
Ken-Ichi Kasahara's contributions to pharmaceutical innovations highlight his commitment to improving health outcomes through research and development. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile